China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.
CPHI stock price ended at $1 on 星期三, after rising 12.36%
On the latest trading day May 13, 2026, the stock price of CPHI rose by 12.36%, climbing from $0.90 to $1.00. Throughout the session, the stock experienced a volatility of 47.50%, with prices fluctuating between a daily low of $0.80 and a high of $1.18. Alongside this price increase, trading volume also rose by 12.0M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 730.4K shares were traded, amounting to a market value of approximately $40.5M.